Medtronic (NYSE:MDT) won’t face some of the so-called "death penalty" sanctions imposed by a Texas state court after an appeals court there reversed a portion of the lower court’s ruling.
Neuromodulation/Neurostimulation
FDA OKs eNeura’s mobile migraine treatment device
Maryland medical device maker eNeura today touted FDA clearance for its SpringTMS system, a mobile magnetic stimulator that can help relieve pain associated with migraines that are preceded by an ‘aura.’
Press Release: eNeura, Inc. Receives FDA Clearance for SpringTMS® Migraine Treatment Device
‘Brain-hacking’ devices may not be safe but they’re selling | MassDevice.com On Call
MASSDEVICE ON CALL — A handful of consumer tech companies are selling neural stimulation devices that they say can improve cognition and sharpen focus, but the tech may pose unexamined risks to users.
Stryker slips pain-pump suit on appeal
Press Release: New Data Presented At WIP 2014 Demonstrate Sustained Low Back Pain Relief With The Boston Scientific Precision Spectra™ Spinal Cord Stimulator System
May 8, 2014
Boston Scientific’s spinal stim targets pain relief with 3D anatomic modeling
Report: Mainstay Medical’s IPO raises $25M
Mainstay Medical‘s (MSTY.PA) European initial public offering reeled in about $25 million (€18 million) and made the spinal implant maker the 1st medtech company to float an IPO in Paris and the 1st company to attempt a dual flotation in Paris and Dublin, the Irish Times reports.
FDA may ban behavioral shock devices
The FDA’s neurological devices panel will meet tomorrow to decide the fate of aversive electrical stimulation, devices that generate electrical shocks used by care providers in order to deter unwanted behavior.
Boston Scientific launches Parkinson’s brain stim registry
Boston Scientific (NYSE:BSX) kicked off a new registry evaluating deep brain stimulation in treatment of Parkinson’s disease.